Advertisement
Advertisement
ORKA
Oruka Therapeutics, Inc. Common Stock
89.92
USDSponsored
-4.63
-4.89%
Sep 23, 16:00 UTC -4
Closed
After-Market
89.61
-0.31
-0.34%
ORKA Earnings Reports
Positive Surprise Ratio
ORKA beat 17 of 19 last estimates.
89%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.61
Implied change from Q2 26 (Revenue/ EPS)
--
/+10.91%
Implied change from Q3 25 (Revenue/ EPS)
--
/+10.91%
Oruka Therapeutics, Inc. Common Stock earnings per share and revenue
On Aug 10, 2026, ORKA reported earnings of -0.55 USD per share (EPS) for Q2 26, missing the estimate of -0.52 USD, resulting in a -4.62% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.40% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.61 USD, with revenue projected to reach -- USD, implying an increase of 10.91% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-Actual
-$0.54
Surprise
-
FAQ
What were Oruka Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Oruka Therapeutics, Inc. Common Stock reported EPS of -$0.55, missing estimates by -4.62%, and revenue of $0.00, 0% as expectations.
How did the market react to Oruka Therapeutics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 6.4%, changed from $98.82 before the earnings release to $105.14 the day after.
When is Oruka Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Oruka Therapeutics, Inc. Common Stock's next earnings report?
Based on 11
analysts, Oruka Therapeutics, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.